The CGNX stock moved lower after hours, trading at $39.49 and down 3.04% on the NASDAQ as investors position ahead of February earnings. This move follows mixed analyst views and fresh institutional flows. We review Cognex Corporation (CGNX) fundamentals, technicals, and analyst targets to assess the AI stocks angle and near-term catalysts for US investors.
Quick performance snapshot for CGNX stock
CGNX stock closed the regular session near $39.49 with a one-day decline of 3.04%. Volume finished at 1,685,722 shares versus average volume 1,871,486. The security trades on NASDAQ in the United States and sits between its 50-day average $38.16 and 200-day average $37.66.
News flow and earnings catalyst shaping CGNX trading
Cognex is set to report quarterly results after the close on 11 Feb 2026; consensus expects $0.22 EPS and $238.92 million revenue. Short-term trading reflects positioning ahead of that print and recent filings showing institutional activity. For background and analyst notes, see MarketBeat coverage and consensus targets source and recent headlines source.
Fundamentals and valuation: what CGNX stock metrics show
Cognex reports EPS $0.65 (TTM) and a P/E near 60.75 on the current price. Key margins are strong: gross margin ~67.65% and operating margin ~16.27%. Balance sheet metrics are healthy: current ratio 3.96, debt to equity 0.05, and free cash flow yield roughly 3.12%. The price-to-sales ratio is 7.04, indicating premium valuation versus hardware peers.
Technicals and trading setup for this AI stocks candidate
Technicals show momentum but mixed breadth. RSI sits near 59.29, ADX indicates a trending move at 25.84, and Bollinger bands center at $36.79. Short-term support is around $38.99 (day low) and resistance near the year high $49.76. Traders note the stock’s beta 1.53, so expect amplified swings versus large-cap tech.
Meyka stock grade, analyst targets and CGNX stock outlook
Meyka AI rates CGNX with a score out of 100: 71.88 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Analyst price targets range from $35.00 (JPMorgan) to $58.00 (UBS) with a MarketBeat consensus of $45.64, implying roughly 15.58% upside from $39.49. These grades are model-driven and not guaranteed; we are not financial advisors. For a Meyka stock page and model details visit our internal summary: Meyka CGNX profile.
Risks and opportunities for CGNX stock investors
Opportunity: Cognex is a leader in machine vision and benefits from automation and AI adoption across manufacturing and logistics. Risk: valuation is rich with P/E above 60.00, and demand cycles in electronics and automotive can compress revenue. Macroeconomic or inventory-cycle shocks could weigh on near-term growth even if longer-term secular trends remain supportive.
Final Thoughts
Key takeaways: CGNX stock trades at $39.49 after hours with a near-term pullback ahead of earnings. Analysts offer a mixed range of price targets, with consensus $45.64 and visible upside of 15.58% to that level. Meyka AI’s forecast model projects a yearly level near $30.64, implying a -22.43% move versus today’s price. Meyka AI’s forecast model projects these levels as model-based scenarios, not guarantees. Investors should weigh premium valuation, upcoming earnings on 11 Feb 2026, and sector trends before acting. Use earnings results and order flow to refine risk sizing in AI stocks exposure.
FAQs
What drives short-term moves in CGNX stock?
Short-term moves in CGNX stock are driven by earnings cadence, order flow from industrial customers, analyst revisions, and institutional trades. Upcoming earnings on 11 Feb 2026 are a key near-term catalyst.
Is CGNX stock overvalued compared with peers?
On standard metrics CGNX stock shows premium valuation: P/E around 60.75 and price-to-sales 7.04. That premium reflects strong margins and market position, but it elevates sensitivity to missed growth.
How should I use Meyka AI data on CGNX stock?
Meyka AI provides model scores, forecasts, and a grade to inform research. Use the CGNX stock grade and forecasts as inputs, then combine with your own analysis and risk profile. These outputs are projections, not trading advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)